Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2018, Article ID 3413592, 5 pages
https://doi.org/10.1155/2018/3413592
Case Report

Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment

1Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
2Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
3Stockton Hematology Oncology Medical Group, Stockton, CA 95204, USA
4Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA 94305, USA

Correspondence should be addressed to Gregory W. Charville; ude.drofnats@cwg

Received 16 July 2018; Accepted 30 July 2018; Published 5 August 2018

Academic Editor: Sorabh Kapoor

Copyright © 2018 Gregory W. Charville et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Gregory W. Charville, Sukhmani K. Padda, Richard K. Sibley, Ajithkumar Puthillath, and Paul Y. Kwo, “Resolution of Crizotinib-Associated Fulminant Hepatitis following Cessation of Treatment,” Case Reports in Hepatology, vol. 2018, Article ID 3413592, 5 pages, 2018. https://doi.org/10.1155/2018/3413592.